Stay updated on Lirentelimab in Eosinophilic Esophagitis Clinical Trial
Sign up to get notified when there's something new on the Lirentelimab in Eosinophilic Esophagitis Clinical Trial page.

Latest updates to the Lirentelimab in Eosinophilic Esophagitis Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe page revision number was updated from v3.6.4 to v3.6.5, indicating a small backend update to the record. This does not alter study content or user-facing information.SummaryDifference0.0%

- Check20 days agoNo Change Detected
- Check28 days agoChange DetectedThe page revision was updated from v3.6.3 to v3.6.4, signaling a new version of the study details page. This appears to be a metadata or maintenance update rather than a change to the study content itself.SummaryDifference0.0%

- Check49 days agoChange DetectedThe page’s revision label was updated from v3.6.2 to v3.6.3, indicating a new revision of the page documentation. This reflects a minor update to the study record’s documentation rather than a substantive change to the study itself.SummaryDifference0.0%

- Check56 days agoChange DetectedRevision: v3.6.2 is now shown on the page, replacing the previous Revision: v3.6.0. This reflects a small update to the page's revision metadata rather than a change to study information.SummaryDifference0.0%

- Check70 days agoChange DetectedThe page now states that recruitment has ended and no longer accepts participants. It also adds new help and navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and updates the Intervention/Treatment label formatting, along with a new revision tag (v3.6.0).SummaryDifference0.2%

- Check78 days agoChange DetectedThe page revision tag was updated from v3.5.4 to v3.5.5, indicating a small update to the page template or rendering. It does not alter the study data or visible information.SummaryDifference0.0%

Stay in the know with updates to Lirentelimab in Eosinophilic Esophagitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lirentelimab in Eosinophilic Esophagitis Clinical Trial page.